Table 2.

Microvascular obstruction in patients treated with and without supersaturated oxygen.

Characteristic	SSO2-treated group (n = 90)	Control group (n = 784)	Unadjusted P
Time to MVO assessment, d	3.8 ± 1.2	3.6 ± 1.5	.23
Extent of MVO, g	0.3 [0.0, 3.4]	1.1 [0.0, 5.2]	.049
Percent MVO, % LV	0.2 [0.0, 2.1]	0.8 [0.0, 3.8]	.052
Any MVO present	48/90 (53.3)	459/784 (58.5)	.35
Infarct size, % LV	20.8 [10.5, 30.4]	24.7 [14.4, 37.3]	.03

Data presented as n/N (%), mean ± SD, or median [Q1, Q3], where applicable.

LV, left ventricular; MVO, microvascular obstruction; SSO₂, supersaturated oxygen.